Literature DB >> 22079928

Early distal axonopathy of the visual pathway in experimental diabetes.

Diego C Fernandez1, Laura A Pasquini, Damián Dorfman, Hernán J Aldana Marcos, Ruth E Rosenstein.   

Abstract

Diabetic retinopathy is a leading cause of acquired blindness. Visual function disorders have been observed in diabetic patients with very early retinopathy or even before the onset of retinopathy. The aim of the present work was to analyze the visual pathway in an early stage of experimental diabetes. Diabetes was induced in Wistar rats by an i.p. injection of streptozotocin. A deficit in anterograde transport from the retina to the superior colliculus was observed 6 weeks after streptozotocin injection. At this time point, morphologic studies did not reveal retinal ganglion cell loss or substantial alterations in the superior colliculus. The optic nerve was morphometrically evaluated at intraorbital (unmyelinated and myelinated) and intracranial sections. In animals that had been diabetic for 6 weeks, a large increase in astrocyte reactivity occurred in the distal (but not the intraorbital) portion, which coincided with significant axon loss. Moreover, profound myelin alterations and altered morphologic features of oligodendrocyte lineage were observed at the distal (but not the proximal) optic nerve portion. The present results suggest that axoglial alterations at the distal portion of the optic nerve could be the first structural change in the diabetic visual pathway.
Copyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22079928      PMCID: PMC3244601          DOI: 10.1016/j.ajpath.2011.09.018

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  48 in total

1.  Diabetic retinopathy viewed as a neurosensory disorder.

Authors:  G H Bresnick
Journal:  Arch Ophthalmol       Date:  1986-07

2.  Steady-state pattern electroretinogram in insulin-dependent diabetics with no or minimal retinopathy.

Authors:  B Falsini; V Porciatti; G Scalia; S Caputo; A Minnella; M A Di Leo; G Ghirlanda
Journal:  Doc Ophthalmol       Date:  1989-10       Impact factor: 2.379

3.  Contrast sensitivity in diabetics with and without background retinopathy.

Authors:  S Sokol; A Moskowitz; B Skarf; R Evans; M Molitch; B Senior
Journal:  Arch Ophthalmol       Date:  1985-01

4.  Effects of hyperglycaemia on visual evoked potentials in insulin-dependent diabetic patients.

Authors:  V Martinelli; P M Piatti; M Filippi; M Pacchioni; M R Pastore; N Canal; G Comi
Journal:  Acta Diabetol       Date:  1992       Impact factor: 4.280

5.  Morphometric analysis of normal, mutant, and transgenic CNS: correlation of myelin basic protein expression to myelinogenesis.

Authors:  H D Shine; C Readhead; B Popko; L Hood; R L Sidman
Journal:  J Neurochem       Date:  1992-01       Impact factor: 5.372

6.  The pattern electroretinogram in diabetes.

Authors:  T C Prager; C A Garcia; C A Mincher; J Mishra; H H Chu
Journal:  Am J Ophthalmol       Date:  1990-03-15       Impact factor: 5.258

7.  Retinocortical conduction time in diabetics with abnormal pattern reversal electroretinograms and visual evoked potentials.

Authors:  G L Trick; R M Burde; M O Gordon; C Kilo; J V Santiago
Journal:  Doc Ophthalmol       Date:  1988-09       Impact factor: 2.379

8.  Optic nerve in diabetes mellitus: a case control study.

Authors:  L Giarelli; G Grandi; M Delendi; G Falconieri
Journal:  Metab Pediatr Syst Ophthalmol (1985)       Date:  1986

9.  Light-dependent retinal innervation of the rat superior colliculus.

Authors:  J Roxanne Prichard; Hilda S Armacanqui; Ruth M Benca; Mary Behan
Journal:  Anat Rec (Hoboken)       Date:  2007-03       Impact factor: 2.064

10.  Expression of a myelin basic protein gene in transgenic shiverer mice: correction of the dysmyelinating phenotype.

Authors:  C Readhead; B Popko; N Takahashi; H D Shine; R A Saavedra; R L Sidman; L Hood
Journal:  Cell       Date:  1987-02-27       Impact factor: 41.582

View more
  23 in total

1.  Aging-related changes of optic nerve of Wistar albino rats.

Authors:  Hassan I H El-Sayyad; Soad A Khalifa; Fawkia I El-Sayyad; Asma S Al-Gebaly; Ahmed A El-Mansy; Ezaldin A M Mohammed
Journal:  Age (Dordr)       Date:  2013-09-01

Review 2.  Research Progress in MRI of the Visual Pathway in Diabetic Retinopathy.

Authors:  Yu-Min Li; Hong-Mei Zhou; Xiang-Yang Xu; He-Shui Shi
Journal:  Curr Med Sci       Date:  2018-12-07

Review 3.  Critical pathogenic events underlying progression of neurodegeneration in glaucoma.

Authors:  David J Calkins
Journal:  Prog Retin Eye Res       Date:  2012-08-01       Impact factor: 21.198

Review 4.  Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment.

Authors:  Steven F Abcouwer; Thomas W Gardner
Journal:  Ann N Y Acad Sci       Date:  2014-03-27       Impact factor: 5.691

5.  Pattern-Reversal Visual Evoked Potentials Tests in Persons with Type 2 Diabetes Mellitus with and without Diabetic Retinopathy.

Authors:  Raghda S Al-Najjar; Nehaya M Al-Aubody; Salah Z Al-Asadi; Majid Alabbood
Journal:  Neurol Res Int       Date:  2020-08-24

6.  Insulin treatment normalizes retinal neuroinflammation but not markers of synapse loss in diabetic rats.

Authors:  Dustin R Masser; Heather D VanGuilder Starkey; Georgina V Bixler; Wendy Dunton; Sarah K Bronson; Willard M Freeman
Journal:  Exp Eye Res       Date:  2014-06-12       Impact factor: 3.467

Review 7.  Impairment of Axonal Transport in Diabetes: Focus on the Putative Mechanisms Underlying Peripheral and Central Neuropathies.

Authors:  Filipa I Baptista; Helena Pinheiro; Catarina A Gomes; António F Ambrósio
Journal:  Mol Neurobiol       Date:  2018-07-12       Impact factor: 5.590

8.  Repeated monitoring of corneal nerves by confocal microscopy as an index of peripheral neuropathy in type-1 diabetic rodents and the effects of topical insulin.

Authors:  Debbie K Chen; Katie E Frizzi; Lucie S Guernsey; Kelsey Ladt; Andrew P Mizisin; Nigel A Calcutt
Journal:  J Peripher Nerv Syst       Date:  2013-12       Impact factor: 3.494

9.  Retrobulbarly injecting nerve growth factor attenuates visual impairment in streptozotocin-induced diabetes rats.

Authors:  Qi-Chang Wang; Wang Sheng; Cai-Jiao Yi; Han Lv; Bei Cheng
Journal:  Int Ophthalmol       Date:  2020-08-10       Impact factor: 2.031

10.  Intraocular pressure fluctuation and neurodegeneration in the diabetic rat retina.

Authors:  Kyoung In Jung; Jung Eun Woo; Chan Kee Park
Journal:  Br J Pharmacol       Date:  2020-04-15       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.